Relay Therapeutics Inc. Common Stock vs Virgin Galactic Holdings, Inc. — how do they compare? Relay Therapeutics Inc. Common Stock trades at $17.46 (market cap $3.82B), while Virgin Galactic Holdings, Inc. trades at $2.96 (market cap $445.69M). The key difference: Relay Therapeutics Inc. Common Stock is far larger — about 8.6× Virgin Galactic Holdings, Inc.'s market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, Virgin Galactic Holdings, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and Virgin Galactic Holdings, Inc. for 69 Days on average.
| RLAY | SPCE | |
|---|---|---|
Market Cap | $3.82B | $445.69M |
Volume | 4,332,079 | 5,128,850 |
Sector | Health | Industrials |
52-Week High | $20.75 | $7.52 |
52-Week Low | $6.03 | $2.17 |
Typical Hold Time | 0 Days | 69 Days |
Enterprise Value | $2.93B | $409.68M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Virgin Galactic (SPCE) trades at $3.01, down 1.95% on the day, reflecting persistent operational losses and a bearish technical outlook. The company continues to burn cash with negative gross and net profit margins, though recent earnings beats and strong ticket demand for future spaceflights offer a glimmer of hope. Cash flow trends show a gradual improvement, with a projected positive net cash flow of $25 million in 2026.
The outlook remains high-risk, high-reward. The path to profitability hinges on the successful commercial launch of Delta flights in 2027. While analyst sentiment is mixed and significant dilution and debt are concerns, the company's unique position in commercial spaceflight presents a speculative opportunity for investors with a long-term horizon and high risk tolerance.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →